Late Breaking Abstract - Clinical efficacy of Tezepelumab in pre-selected non-Type 2 asthma patients - Vienna 2024

Clinical aspects in chronic airway diseases

Chair(s): Christer Janson, Francisco-Javier Gonzalez Barcala

Session type: Poster session

Late Breaking Abstract - Clinical efficacy of Tezepelumab in pre-selected non-Type 2 asthma patients

Timothy Chin-See-Chong

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Factors affecting asthma control in pregnant women with asthma.

Kaleem Toori

Poster

Abstract

Managing Small Airway Disease in patients with severe asthma: transitioning from the "Silent Zone" to achieving "Quiet Asthma"

Francesca Montagnolo

Poster

Abstract

Efficacy of inhaled corticosteroid and bronchodilator in patients with persistent respiratory symptoms post COVID-19 infection: a retrospective analysis

Shih-en Tang

Abstract

Investigating the important factors influencing long-term doxycycline responsiveness in COPD

Debkanya Dey

Poster

Abstract

Comparison of effectiveness of acetylcysteine and 3% hypertonic saline inhalation in patients with COPD

Dmytro Dobrianskyi

Poster

Abstract

Management of patients with confirmed large airway collapse

Rachel Burton

Poster

Abstract

FASE 2 - CPHG: Initial findings of an observational study of patients with severe asthma treated in French non-academic hospitals.

Laurent Portel

Poster

Abstract

Mucus dispersal by Dithiothreitol (DTT) reduces ciliary dyskinesia

Anna Straatman-iwanowska

Poster

Abstract

Inter-patient variability of inhaled medication lung deposition using Functional Respiratory Imaging (FRI)

Hosein Sadafi

Poster

Abstract

Domiciliary nasal high flow therapy for breathlessness; chronic obstructive pulmonary disease (COPD)

Natasha Smallwood

Poster

Abstract

Respiratory clinicians attitudes to offering rescue packs to patients discharged after COPD exacerbation

John R Hurst

Poster

Abstract

Measures of lung function and inflammation in patients hospitalised with severe asthma attacks and 2 weeks later

Mouaid Aljehani

Poster

Abstract

The societal cost of asthma among young adults in Sweden a register-based study

Alma Rovsing

Poster

Abstract

Efficacy and safety of axatilimab at 3 different doses in patients with chronic graft-versus-host disease (cGVHD) and related bronchiolitis obliterans syndrome (BOS): results of a pivotal phase 2 study

Amandeep Salhotra

Poster

Abstract

Reduced tracheal stenosing effect of nintedanib in a patient with scarred posttraumatic tracheal stenosis and airflow limitation

Stefanie Klampfleitner

Poster

Abstract

Bronchiectasis in severe asthma: clinical and inflammatory response to biologic therapy.

Alice Villa

Poster

Abstract

"The earlier the better", evolution of Pulmonary Function Tests (PFT) in severe asthma patients treated with Benralizumab after two years.

Pablo Franco Su?rez

Poster

Abstract

Evaluation of the association between nutritional status and socioeconomic factor with lung function in PCD Patients in the UK

Ran An

Poster

Abstract

Social determinants of health in clinical trials of long-term oral antibiotics in COPD: a systematic review

Natasha Smallwood

Poster

Abstract

Late Breaking Abstract - Clinical efficacy of Tezepelumab in pre-selected non-Type 2 asthma patients

Timothy Chin-see-chong

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}